Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
rbGgeDCqVwSwqZ84